Levofloxacine Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacine Fresenius Kabi, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It is employed to treat a broad spectrum of serious bacterial infections in adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Levofloxacine Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets, and timely delivery.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, abdominal and skin systems.

- Community‑acquired pneumonia: rapid bacterial clearance leading to clinical improvement. - Hospital‑acquired pneumonia: effective against resistant pathogens to support recovery. - Complicated urinary tract infections: eradicates causative organisms and resolves infection. - Complicated intra‑abdominal infections: aids in controlling polymicrobial infection after surgery. - Skin and soft tissue infections: reduces bacterial load and promotes healing. - Acute bacterial sinusitis: alleviates symptoms by eliminating the infecting bacteria.

Levofloxacin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT prolongation: cardiac rhythm disturbances that may lead to arrhythmia. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome requiring urgent care.

When prescribing Levofloxacin, clinicians should consider several safety precautions to minimize risk.

- Renal impairment: adjust dose or monitor renal function closely. - History of tendon disorders: avoid use or discontinue at first sign of tendon pain. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm and electrolytes. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Allergic reactions: discontinue if signs of hypersensitivity develop. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption; separate administration by at least 2 hours. - Warfarin: may increase INR and bleeding risk; monitor coagulation parameters. - Theophylline: increased plasma levels leading to toxicity; consider dose reduction.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Diabetic agents (e.g., insulin, sulfonylureas): potential for hypoglycemia; monitor blood glucose. - Corticosteroids: heightened risk of tendon rupture; advise caution.